A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancerRicardo Hitt, Javier García, Carlos García Girón et al.|Annals of Oncology|2013Cited by 351
Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neckRicardo Hitt, Juan Jesús Cruz, Antonio Irigoyen López et al.|Annals of Oncology|2011Cited by 222